BioSpace News Archive

Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in mobile, affordable, point-of-care diagnostics, today announced that it has received ISO 13485:2016 certification for its new facility in San Leandro, California.

On April 27, 2022, GyroStim became the first FDA-cleared device for treating balance disorders to receive FDA designation as a Breakthrough Device.

Navidea Biopharmaceuticals, Inc. announced today that it has extended the initial rights offering subscription period until 5:00 PM Eastern time on Wednesday, August 24, 2022 and has updated certain pricing information for its rights offering.

SYNERGEN Health, an innovator in healthcare revenue cycle management solutions, today announces it has been ranked as the 1,511th overall fastest-growing private company in the nation.

CorDx, a global leader in the development, manufacturing, and distribution of diagnostics and medical devices, was recently granted a CE Mark certificate for two of the company’s monkeypox diagnostic tests.

KRTL Holding Group, Inc. is pleased to announce its wholly owned subsidiary, KRTL Biotech, Inc., an international research, and development company, has appointed Dr. Malcolm A. Leissring as its founding Chief Science Officer.

Almirall, LLC, a global biopharmaceutical company focused on skin health, announced its microtubule inhibitor ointment, KLISYRI® (tirbanibulin), a topical field treatment for actinic keratosis (AK) of the face and scalp, received a strong recommendation designation in the AAD’s American Academy of Dermatology’s Focused Update to the Guidelines of Care for the Management of Actinic Keratosis.

Qualigen Therapeutics, Inc. (Nasdaq: QLGN), today announces it has formed a Scientific Advisory Board (SAB) in support of the development of its lead therapeutic candidate QN-302 for the potential treatment of pancreatic cancer and other G4-prevalent solid tumors.

Henlius is committed to offering high-quality, affordable and innovative biopharmaceuticals to patients worldwide with 5 products launched in China, 1 in global, 13 indications approved and 4 New Drug Applications now accepted by the National Medical Products Administration, focusing on oncology, autoimmune diseases, ophthalmic diseases, etc.

Konica Minolta Healthcare Americas Inc. is sponsoring a lunch and learn educational session that will highlight the benefits of adding diagnostic and interventional ultrasound procedures at the Physician Assistant in Orthopaedic Surgery (PAOS) 2022 Annual CME Conference.